These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 29394533)

  • 1. [A Case of T1a Breast Cancer with Axillary Lymph Node Metastasis].
    Tsujio G; Kashiwagi S; Asano Y; Goto W; Takada K; Morisaki T; Noda S; Takashima T; Onoda N; Ohsawa M; Hirakawa K; Ohira M
    Gan To Kagaku Ryoho; 2017 Nov; 44(12):1059-1061. PubMed ID: 29394533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolated retromammary lymph node metastasis of breast cancer without axillary lymph node involvement: a case report with a false-negative sentinel lymph node biopsy.
    Rokutanda N; Horiguchi J; Koibuchi Y; Nagaoka R; Sato A; Odawara H; Tokiniwa H; Iino Y; Hirato J; Takeyoshi I
    Breast Cancer; 2009; 16(2):162-5. PubMed ID: 19242778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A Case of Breast Cancer with Infarcted Necrosis That Was Diagnosed Based on Axillary Lymph Node Metastasis].
    Kinoshita H; Teraoka H; Maekawa Y; Kitano M; Morikawa M; Sugita Y; Sakamoto A; Uono H; Mori T; Hasegawa T; Noda E; Chikugo T; Kashiwagi S; Hirakawa K; Ohira M
    Gan To Kagaku Ryoho; 2018 Dec; 45(13):2217-2219. PubMed ID: 30692336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions.
    White RE; Vezeridis MP; Konstadoulakis M; Cole BF; Wanebo HJ; Bland KI
    J Am Coll Surg; 1996 Dec; 183(6):575-82. PubMed ID: 8957459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maximizing the Clinical Benefit of Anthracyclines in Addition to Taxanes in the Adjuvant Treatment of Early Breast Cancer.
    Curigliano G; Criscitiello C
    J Clin Oncol; 2017 Aug; 35(23):2600-2603. PubMed ID: 28661760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic value of sentinel lymph node micrometastases in patients with invasive breast carcinoma.
    Cipolla C; Graceffa G; La Mendola R; Fricano S; Fricano M; Vieni S
    Ann Ital Chir; 2015; 86():497-502. PubMed ID: 26898168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphatic mapping and sentinel lymphadenectomy in early stage breast carcinoma.
    Altinyollar H; Kapucuoglu N; Pak I; Berberoglu U
    J Exp Clin Cancer Res; 2000 Jun; 19(2):141-4. PubMed ID: 10965808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metachronous secondary primary occult breast cancer initially presenting with metastases to the contralateral axillary lymph nodes: report of a case.
    Kinoshita S; Hirano A; Kobayashi S; Komine K; Kyoda S; Takeyama H; Uchida K; Morikawa T; Nagase J; Sakamoto G
    Breast Cancer; 2010; 17(1):71-4. PubMed ID: 19259764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CDX2-positive breast cancer presented with axillary lymph node metastases: A case report.
    Hoshina H; Takei H; Sakatani T; Naito Z
    Cancer Treat Res Commun; 2021; 26():100300. PubMed ID: 33421821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].
    Sávolt A; Musonda P; Mátrai Z; Polgár C; Rényi-Vámos F; Rubovszky G; Kovács E; Sinkovics I; Udvarhelyi N; Török K; Kásler M; Péley G
    Orv Hetil; 2013 Dec; 154(49):1934-42. PubMed ID: 24292111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Second biopsy of axillary sentinel lymph node for reappearing breast cancer after previous sentinel lymph node biopsy.
    Intra M; Trifirò G; Viale G; Rotmensz N; Gentilini OD; Soteldo J; Galimberti V; Veronesi P; Luini A; Paganelli G; Veronesi U
    Ann Surg Oncol; 2005 Nov; 12(11):895-9. PubMed ID: 16195833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contralateral axillary metastases from breast cancer. Personal experience and review of literature.
    Pasta V; Urciuoli P; D'Orazi V; Sottile D; Monti M; Redler A
    Ann Ital Chir; 2014; 85(3):260-4. PubMed ID: 24662239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Demonstration of the sentinel lymph node in axillary dissection for breast cancer].
    Salmon RJ; Fried D
    Presse Med; 1998 Mar; 27(11):509-12. PubMed ID: 9767960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term prognoses and outcomes of axillary lymph node recurrence in 2,578 sentinel lymph node-negative patients for whom axillary lymph node dissection was omitted: results from one Japanese hospital.
    Ogiya A; Kimura K; Nakashima E; Sakai T; Miyagi Y; Iijima K; Morizono H; Makita M; Horii R; Akiyama F; Iwase T
    Breast Cancer; 2016 Mar; 23(2):318-22. PubMed ID: 25376341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sentinel lymph node biopsy is not necessary in patients diagnosed with ductal carcinoma in situ of the breast by stereotactic vacuum-assisted biopsy.
    Kotani H; Yoshimura A; Adachi Y; Ishiguro J; Hisada T; Ichikawa M; Gondou N; Hattori M; Kondou N; Sawaki M; Fujita T; Iwata H
    Breast Cancer; 2016 Mar; 23(2):190-4. PubMed ID: 24989112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors predicting non-sentinel lymph node involvement in sentinel node positive breast carcinoma.
    Durak MG; Akansu B; Akin MM; Sevınç AI; Koçdor MA; Saydam S; Harmancioğlu O; Ellıdokuz H; Bekış R; Canda T
    Turk Patoloji Derg; 2011; 27(3):189-95. PubMed ID: 21935867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term follow-up of 5262 breast cancer patients with negative sentinel node and no axillary dissection confirms low rate of axillary disease.
    Galimberti V; Manika A; Maisonneuve P; Corso G; Salazar Moltrasio L; Intra M; Gentilini O; Veronesi P; Pagani G; Rossi E; Bottiglieri L; Viale G; Rotmensz N; De Cicco C; Grana CM; Sangalli C; Luini A
    Eur J Surg Oncol; 2014 Oct; 40(10):1203-8. PubMed ID: 25186914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Completion axillary lymph node dissection not required for regional control in patients with breast cancer who have micrometastases in a sentinel node.
    Yegiyants S; Romero LM; Haigh PI; DiFronzo LA
    Arch Surg; 2010 Jun; 145(6):564-9. PubMed ID: 20566977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of invasion and axillary lymph node metastasis in ductal carcinoma in situ diagnosed by core-needle biopsy.
    Meijnen P; Oldenburg HS; Loo CE; Nieweg OE; Peterse JL; Rutgers EJ
    Br J Surg; 2007 Aug; 94(8):952-6. PubMed ID: 17440955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.